Emergent BioSolutions | Des Atouts

Assets Changement Date
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amarin USD 839.03M 20.99M 2023-09
ANI Pharmaceuticals USD 904.42M 14.51M 2023-12
Exact Sciences USD 6.47B 50.5M 2023-12
Exelixis USD 2.98B 165.56M 2023-09
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Ironwood Pharmaceuticals USD 471.07M 52.99M 2023-12
Lonza CHF 17.67B 316M 2023-06
Merck USD 106.73B 2.26B 2023-09
Moderna USD 18.43B 1.02B 2023-12
Myriad Genetics USD 1.15B 2.6M 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pacira USD 1.57B 39.92M 2023-12
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
United Therapeutics USD 7.17B 143.4M 2023-12



Emergent BioSolutions Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.